Skip navigation

Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters

Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters

BTG International Limited (2006) Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters. PCT/GB2006/000778.

Full text not available from this repository.

Abstract

A method of treating a patient in need of therapy for a cytokine dysregulation comprising administering to that patient a therapeutically effective dose of a monoglyceride or metabolic precursor thereof of general formula (I), wherein R1 is the a fatty acyl group of an essential poyunsaturated fatty acid selected from ϝ-linolenoyl, ϝ-dihomolinolenoyl and arachidonoyl.

Item Type: Patent
Additional Information: Pub. No.: WO/2006/092622 International Application No.: PCT/GB2006/000778 Publication Date: 08.09.2006 International Filing Date: 02.03.2006
Uncontrolled Keywords: Polyunsaturated fatty acids, neurodegenerative diseases
Subjects: R Medicine > RM Therapeutics. Pharmacology
Faculty / Department / Research Group: Faculty of Engineering & Science > Department of Life & Sports Sciences
Related URLs:
Last Modified: 17 Oct 2016 09:10
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
URI: http://gala.gre.ac.uk/id/eprint/4324

Actions (login required)

View Item View Item